ArticleBMJ case reports2022

T-cell prolymphocytic leukaemia associated with immune checkpoint inhibitor (pembrolizumab).

Alzira R Avelino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.